2022
DOI: 10.3389/fendo.2022.987942
|View full text |Cite
|
Sign up to set email alerts
|

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma

Abstract: BackgroundCopper is an indispensably mineral element involved in various metabolic processes and functions in the active sites of many metalloproteins. Copper dysregulation is associated with cancers such as osteosarcoma (OS), the most common primary bone malignancy with invasiveness and metastasis. However, the causality between cuproptosis and OS remains elusive. We aim to identify cuproptosis-related long non-coding RNAs (lncRNAs) for osteosarcomatous prognosis, immune microenvironment response, and immunot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 43 publications
0
14
0
Order By: Relevance
“…For instance, colon cancer prognosis prediction utility of ferroptosis-related lncRNA signature was demonstrated by Wu et al (2021a) . In addition, our previous study has proved that the cuproptosis-related lncRNA signature (CRLncSig) could use for the prognosis prediction of osteosarcoma ( Liu et al, 2022 ). However, the relationship between cuproptosis-related lncRNAs (CRLs) and STS and their predictive value is not clear so far.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, colon cancer prognosis prediction utility of ferroptosis-related lncRNA signature was demonstrated by Wu et al (2021a) . In addition, our previous study has proved that the cuproptosis-related lncRNA signature (CRLncSig) could use for the prognosis prediction of osteosarcoma ( Liu et al, 2022 ). However, the relationship between cuproptosis-related lncRNAs (CRLs) and STS and their predictive value is not clear so far.…”
Section: Introductionmentioning
confidence: 99%
“…In terms of ongoing or future studies that explore the therapeutic targeting of cuproptosis in ACC, there indeed exist studies that investigate cuproptosis as a mechanism and potential intervention target in various diseases 31–33 . For instance, the use of copper chelators, inhibitors of copper chaperone proteins, and copper ionophores could potentially serve as therapeutics targeting cuproptosis in cardiovascular diseases 31 .…”
Section: Discussionmentioning
confidence: 99%
“…All cell lines were cultured at 37 °C in a humidified atmosphere with 5% carbon dioxide. RNA extraction, cDNA synthesis, and RT-qPCR reactions were performed according to the procedures described in previous studies ( Liu et al, 2022a ; Liu et al, 2022b ). Meanwhile, GAPDH was selected as an internal reference, and the relative expression of FRGs was calculated through the 2 −ΔΔCT method.…”
Section: Methodsmentioning
confidence: 99%